Does Metformin Help Decrease Chances of Prostate Cancer?

Posted at 8th September 2013 by Ryan Luce

written by Michael O’Leary

Metformin may be the aspirin of type 2 diabetes. It just seems as if the benefits of metformin therapy seem to grow the more researchers study it.

A case in point is new study published online last week in the Journal of Clinical Oncology.  It showed that men with type 2 diabetes and prostate cancer lived longer and were much less likely to die of prostate cancer when treated with metformin.

Do anti-psychotics and antidepressants cause diabetes?

Posted at 28th August 2013 by Ryan Luce

written by Michael O’Leary

The headlines about anti-psychotic drugs tripling the risk of type 2 diabetes is bad enough, but coupled with a seven-fold increase in the number of kids being prescribed these anti-psychotic drugs leaves one to wonder.

What are we doing to our kids?

Dr. Wayne Ray of Vanderbilt University

Are GLP-1 Drugs Such as Januvia and Byetta Worth It?

Posted at 26th March 2013 by Ryan Luce

written by Michael O’Leary

Good news, bad news for people taking new class of type 2 diabetes drugs…

People with type 2 diabetes who take one of the newer add-on drugs have been whipsawed by the news this past week that on the one hand their drugs might lower their risk of being hospitalized for heart failure, while on the other the drugs might increase their risk of pancreatitis.

Is Oral Insulin on the Way?

Posted at 25th February 2013 by Ryan Luce

written by Michael O’Leary

Two companies announced clinical trials in the last three weeks aimed at bringing insulin taken by mouth to market.

Generex Biotechnology Corporation announced at the end of January results of a phase III clinical trial showing that its oral insulin spray Oral-lyn™ is as effective as subcutaneously injected regular insulin. The 12-week study conducted by an Indian licensee of Generex involved 209 men and women with type 2 diabetes at 14 clinics in India who did not have well controlled blood sugar levels with oral diabetic drugs.

More Evidence for Surgery for Type 2 Diabetes?

Posted at 31st December 2012 by Ryan Luce

Written by Michael O'Leary

Edward Gregg, Ph.D.

Intensive lifestyle changes including diet and exercise were significantly more effective than standard counseling and medications for reversing type 2 diabetes, an ongoing federal study shows. But the success rate may add fuel to the debate for those advocating surgery as a more effective method of reversing the disease.

Funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), theLook AHEAD: Action for Health in Diabetes study began in 2001 and continues today, but is no longer recruiting participants.

Is Victoza Better Than Bydureon?

Posted at 2nd December 2012 by Ryan Luce

written by Michael O’Leary

In a head-to-head comparison of the daily type 2 diabetes drug Victoza and weekly injections of Bydureon, those taking the daily drug did significantly better in lowering their HbA1c than those taking the weekly injections.

The down side was that those taking the higher than normal dose of Victoza had more side effects.

Good News For Potential Approval of Tresiba – A New Long-Acting Insulin

Posted at 25th November 2012 by Ryan Luce

written by Michael O’Leary

Last week an FDA advisory panel recommended degludec, a once-daily injectable insulin, be approved by the FDA, but will require Novo Nordisk to conduct additional trials to assess the heart risk that may be posed by the drug.

As reported by Fierce Biotech, Reuters and others the outside panel of non-FDA medical experts recommended approval by an 8-4 vote, but unanimously voted to require additional studies to assess the heart risk.
(published site)